vs
Side-by-side financial comparison of Amneal Pharmaceuticals, Inc. (AMRX) and Century Communities, Inc. (CCS). Click either name above to swap in a different company.
Century Communities, Inc. is the larger business by last-quarter revenue ($789.7M vs $722.5M, roughly 1.1× Amneal Pharmaceuticals, Inc.). Amneal Pharmaceuticals, Inc. runs the higher net margin — 10.8% vs 3.1%, a 7.7% gap on every dollar of revenue. On growth, Amneal Pharmaceuticals, Inc. posted the faster year-over-year revenue change (3.9% vs -12.6%). Over the past eight quarters, Amneal Pharmaceuticals, Inc.'s revenue compounded faster (1.5% CAGR vs -12.8%).
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.
20th Century Animation, Inc. is an American animation studio located in Century City, Los Angeles, until its lease with Fox Corporation ended and it was relocated to the Walt Disney Studios in Burbank. Walt Disney Studios Motion Pictures distributes and markets the films produced by this studio in theatrical markets. Formed in February 1994, it is organized as a division and label of 20th Century Studios, a subsidiary of the Walt Disney Studios, and is tasked with producing animated feature-l...
AMRX vs CCS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $722.5M | $789.7M |
| Net Profit | $78.0M | $24.4M |
| Gross Margin | 44.3% | — |
| Operating Margin | 19.6% | — |
| Net Margin | 10.8% | 3.1% |
| Revenue YoY | 3.9% | -12.6% |
| Net Profit YoY | 410.5% | -38.0% |
| EPS (diluted) | $0.19 | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $722.5M | $789.7M | ||
| Q4 25 | $814.3M | $1.2B | ||
| Q3 25 | $784.5M | $980.3M | ||
| Q2 25 | $724.5M | $1.0B | ||
| Q1 25 | $695.4M | $903.2M | ||
| Q4 24 | $730.5M | $1.3B | ||
| Q3 24 | $702.5M | $1.1B | ||
| Q2 24 | $701.8M | $1.0B |
| Q1 26 | $78.0M | $24.4M | ||
| Q4 25 | $35.1M | $36.0M | ||
| Q3 25 | $2.4M | $37.4M | ||
| Q2 25 | $22.4M | $34.9M | ||
| Q1 25 | $12.2M | $39.4M | ||
| Q4 24 | $-31.1M | $102.7M | ||
| Q3 24 | $-156.0K | $83.0M | ||
| Q2 24 | $6.0M | $83.7M |
| Q1 26 | 44.3% | — | ||
| Q4 25 | 36.5% | — | ||
| Q3 25 | 34.9% | — | ||
| Q2 25 | 39.5% | — | ||
| Q1 25 | 36.8% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 38.4% | — | ||
| Q2 24 | 35.6% | — |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 13.8% | 3.8% | ||
| Q3 25 | 9.0% | 4.9% | ||
| Q2 25 | 15.4% | 4.7% | ||
| Q1 25 | 14.4% | 5.8% | ||
| Q4 24 | 10.4% | 10.6% | ||
| Q3 24 | 12.6% | 9.7% | ||
| Q2 24 | 13.6% | 10.6% |
| Q1 26 | 10.8% | 3.1% | ||
| Q4 25 | 4.3% | 2.9% | ||
| Q3 25 | 0.3% | 3.8% | ||
| Q2 25 | 3.1% | 3.5% | ||
| Q1 25 | 1.8% | 4.4% | ||
| Q4 24 | -4.3% | 8.1% | ||
| Q3 24 | -0.0% | 7.3% | ||
| Q2 24 | 0.9% | 8.1% |
| Q1 26 | $0.19 | $0.88 | ||
| Q4 25 | $0.10 | $1.21 | ||
| Q3 25 | $0.01 | $1.25 | ||
| Q2 25 | $0.07 | $1.14 | ||
| Q1 25 | $0.04 | $1.26 | ||
| Q4 24 | $-0.10 | $3.20 | ||
| Q3 24 | $0.00 | $2.59 | ||
| Q2 24 | $0.02 | $2.61 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $197.7M | $78.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $2.6B |
| Total Assets | $3.5B | $4.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $197.7M | $78.2M | ||
| Q4 25 | $282.0M | $109.4M | ||
| Q3 25 | $201.2M | $130.1M | ||
| Q2 25 | $71.5M | $93.2M | ||
| Q1 25 | $59.2M | $100.3M | ||
| Q4 24 | $110.6M | $150.0M | ||
| Q3 24 | $74.0M | $149.2M | ||
| Q2 24 | $43.8M | $106.7M |
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | — |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $-70.8M | $2.6B | ||
| Q3 25 | $-109.5M | $2.6B | ||
| Q2 25 | $-112.1M | $2.6B | ||
| Q1 25 | $-131.7M | $2.6B | ||
| Q4 24 | $-109.3M | $2.6B | ||
| Q3 24 | $-93.4M | $2.5B | ||
| Q2 24 | $-57.5M | $2.5B |
| Q1 26 | $3.5B | $4.5B | ||
| Q4 25 | $3.7B | $4.5B | ||
| Q3 25 | $3.6B | $4.7B | ||
| Q2 25 | $3.4B | $4.6B | ||
| Q1 25 | $3.4B | $4.6B | ||
| Q4 24 | $3.5B | $4.5B | ||
| Q3 24 | $3.5B | $4.8B | ||
| Q2 24 | $3.5B | $4.3B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMRX
Segment breakdown not available.
CCS
| Home sales revenues | $734.1M | 93% |
| Land sales and other revenues | $33.2M | 4% |
| Financial services revenues | $22.4M | 3% |
